China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, multicenter, prospective clinical study of irinotecan hydrochloride liposomal(II) in combination with apatinib in the treatment of patients with recurrent small cell lung cancer and liver metastasis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133877
Registration Time: 2026/10/09
Type: Interventional study
Primary Sponsor: Harbin Medical University cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=314791
Published by HT Digital Content Services with permission from Health Daily Digest....